Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Runzao Qingfei Gao for acute tracheobronchitis or acute exacerbation of chronic bronchitis
CTR20180010Phase 2Active
- Sponsor
- Dong-E-E-Jiao
- Start
- Jan 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Runzao Qingfei Gao in tracheobronchitis, chronic bronchitis (CB), sponsored by Dong-E-E-Jiao. Started Jan 2018; status: active.
02
Drugs
Runzao Qingfei Gao
03
Conditions
tracheobronchitischronic bronchitis (CB)
Beyond the preview
Go deeper on CTR20180010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180010.